Cyanocobalamin
Cyanocobalamin Injection, USP
Approved
Approval ID
e559c6c8-2973-77fb-e053-2995a90af43d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 16, 2023
Manufacturers
FDA
SOLA Pharmaceuticals
DUNS: 080121345
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cyanocobalamin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70512-840
Application NumberANDA215417
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cyanocobalamin
Product Specifications
Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUS
Effective DateNovember 16, 2023
FDA Product Classification
INGREDIENTS (6)
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
CYANOCOBALAMINActive
Quantity: 1000 ug in 1 mL
Code: P6YC3EG204
Classification: ACTIB
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT